Format

Send to

Choose Destination
Am J Hosp Palliat Care. 2004 Mar-Apr;21(2):95-104.

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

Author information

1
Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

Abstract

Cannabis (marijuana) has been proposed as treatment for a widening spectrum of medical conditions and has many properties that may be applicable to the management of amyotrophic lateral sclerosis (ALS). This study is the first, anonymous survey of persons with ALS regarding the use of cannabis. There were 131 respondents, 13 of whom reported using cannabis in the last 12 months. Although the small number of people with ALS that reported using cannabis limits the interpretation of the survey findings, the results indicate that cannabis may be moderately effective at reducing symptoms of appetite loss, depression, pain, spasticity, and drooling. Cannabis was reported ineffective in reducing difficulties with speech and swallowing, and sexual dysfunction. The longest relief was reported for depression (approximately two to three hours).

PMID:
15055508
DOI:
10.1177/104990910402100206
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center